What changed from existing technology?
This study used a type of medical scan called 18F-FDG PET/CT to look at cancer features and predict how long patients with colorectal cancer might live.
This is the first study to combine radiomic features from PET/CT scans with clinical data to predict survival in colorectal cancer patients.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 1
Prediction of overall survival in patients with colorectal cancer using baseline 18F-FDG PET/CT radiomics. To predict 3-year overall surv
Title ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This model could help doctors better estimate the prognosis of colorectal cancer patients and guide treatment decisions.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.